Complete Response to Single-agent Palbociclib in Metastatic Breast Cancer: A Case Report

Sri Lakshmi Hyndavi Yeruva, Mehrbod Som Som Javadi, Vered Stearns

Research output: Contribution to journalArticle

Original languageEnglish (US)
JournalClinical Breast Cancer
StateAccepted/In press - Jan 1 2018


  • Biomarkers
  • CDK inhibitors
  • Complete response
  • Metastatic breast cancer
  • Palbociclib

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this